These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Commentary: unapproved uses, dosages, or indications in dermatology: a physician's reference. Wolf R Clin Dermatol; 2002; 20(5):465-6. PubMed ID: 12435515 [No Abstract] [Full Text] [Related]
4. Botulinum toxin for treatment of primary chronic headache disorders. Samson D Technol Eval Cent Assess Program Exec Summ; 2004 Dec; 19(10):1-3. PubMed ID: 15637810 [No Abstract] [Full Text] [Related]
5. Safety and efficacy of a rapid-acting topical 4% lidocaine gel in a unique drug delivery system. Baumann LS; Grunebaum L; Elsaie ML; Murdock J; Jablonka E; Figueras K; Bell M J Drugs Dermatol; 2010 Dec; 9(12):1500-4. PubMed ID: 21120257 [TBL] [Abstract][Full Text] [Related]
7. Oral disorders: unapproved treatments or indications. Tüzün B; Tüzün Y; Wolf R Clin Dermatol; 2000; 18(2):197-200. PubMed ID: 10742629 [No Abstract] [Full Text] [Related]
8. Botulinum toxin type a: once feared, now revered. Rohrich RJ; Janis JE Plast Reconstr Surg; 2003 Feb; 111(2):867-8. PubMed ID: 12560715 [No Abstract] [Full Text] [Related]
9. Bullous diseases: unapproved treatments or indications. Ruocco V; Ruocco E; Wolf R Clin Dermatol; 2000; 18(2):191-5. PubMed ID: 10742628 [No Abstract] [Full Text] [Related]
10. Determining the technical and clinical factors associated with pain for children undergoing botulinum toxin injections under nitrous oxide and anesthetic cream. Brochard S; Blajan V; Lempereur M; Garlantezec R; Houx L; Le Moine P; Peudenier S; Lefranc J; Rémy-Néris O Eur J Paediatr Neurol; 2011 Jul; 15(4):310-5. PubMed ID: 21273098 [TBL] [Abstract][Full Text] [Related]
11. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications. Koo JY; Ng TC Clin Dermatol; 2002; 20(5):582-94. PubMed ID: 12435529 [No Abstract] [Full Text] [Related]
12. Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy. O'Flaherty SJ; Janakan V; Morrow AM; Scheinberg AM; Waugh MC Dev Med Child Neurol; 2011 Feb; 53(2):125-30. PubMed ID: 21244412 [TBL] [Abstract][Full Text] [Related]
15. Psoriasis, lichen planus, and disorders of keratinization: unapproved treatments or indications. Capella GL; Finzi AF Clin Dermatol; 2000; 18(2):159-69. PubMed ID: 10742624 [No Abstract] [Full Text] [Related]
16. [Aesthetic dermatology. Botulinumtoxin A and soft tissue augmentation]. Rauch L; Ruzicka T Hautarzt; 2004 Jul; 55(7):621-9. PubMed ID: 15103418 [TBL] [Abstract][Full Text] [Related]
17. Safer practice of dermatosurgery. Rao KH; Indian J Dermatol Venereol Leprol; 2008 Jan; 74 Suppl():S75-7. PubMed ID: 18688108 [No Abstract] [Full Text] [Related]
18. Acne, perioral dermatitis, flushing, and rosacea: unapproved treatments or indications. Katsambas AD; Nicolaidou E Clin Dermatol; 2000; 18(2):171-6. PubMed ID: 10742625 [No Abstract] [Full Text] [Related]
19. Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Soudant DL; Staal HM; Witlox AM; Vles JS Eur J Paediatr Neurol; 2013 Mar; 17(2):219-20. PubMed ID: 22871256 [No Abstract] [Full Text] [Related]
20. Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Forrester M; Srinivasan J; Mihrshahi S; Waugh M; O'Flaherty S; Rice J; Graham K; Scheinberg A Eur J Paediatr Neurol; 2012 Mar; 16(2):215-7. PubMed ID: 21849252 [No Abstract] [Full Text] [Related] [Next] [New Search]